OPKO PHARMACEUTICALS LLC has a total of 64 patent applications. It increased the IP activity by 25.0%. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are APIM THERAPEUTICS AS, GASTROTECH PHARMA AS and COGNOSCI INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 6 | |
#4 | Taiwan | 6 | |
#5 | United States | 6 | |
#6 | Republic of Korea | 5 | |
#7 | Mexico | 5 | |
#8 | Canada | 4 | |
#9 | China | 4 | |
#10 | Brazil | 3 | |
#11 | Chile | 3 | |
#12 | Colombia | 2 | |
#13 | Japan | 2 | |
#14 | Argentina | 1 | |
#15 | EAPO (Eurasian Patent Organization) | 1 | |
#16 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Frost Phillip | 21 |
#2 | Moola Muralidhar Reddy | 19 |
#3 | Schilke Jessica | 18 |
#4 | Santos Arturo | 17 |
#5 | Kodadek Thomas | 7 |
#6 | Fedotev Irina | 5 |
#7 | Gutman Arie | 5 |
#8 | Rukhman Igor | 5 |
#9 | Ahmed Tahir | 5 |
#10 | Grossman Olga | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020231670A1 | Triamcinolone acetonide-loaded liposomes topical ophthalmic formulations for prevention of macular thickening and its associated visual outcomes after lens surgery | |
US2019321467A1 | Liposome formulations | |
KR20210027230A | Articles and methods for personalized treatment of cancer | |
US2019185503A1 | Pure heptasulfated disaccharides having improved oral bioavailability | |
EP2887958A2 | Liposome formulations | |
MX2013011000A | Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics. | |
EP2663321A2 | Antigen surrogates in autoimmune disease | |
MX2013004975A | Novel vaccines against pandemic influenza virus a/h1n1. | |
AU2006337093A1 | Compositions and methods for regulating complement system | |
AU2003224087A1 | Means and methods for the specific inhibition of genes in cells and tissue of the CNS and/or eye |